Mercodia Webinar: Dr. Ralph DeFronzo: Glucagon Release with SGLT2 Inhibition
Increased glucose excretion through SGLT2 inhibition is a new mode of treatment for type 2 diabetes mellitus (T2DM). During this webinar, Dr. DeFronzo will present intriguing results showing a paradoxical increase in glucagon and endogenous glucose production with SGLT2 inhibition.
▶︎
Mercodia webinar: Dr. J. Domínguez-Bendala and Dr. P. Herrera: Beta Cell Regeneration: Novel Sources
▶︎
Mercodia Webinar: The Gut Microbiota in Diabetes
▶︎
lofi hip hop radio 📚 beats to relax/study to
▶︎
Dr. Gilbert Hosts: The Many Forms of Carbidopa/Levodopa
▶︎
Discussion 2. Top Myths of Diabetes. - Dr. Bernstein's Diabetes University
▶︎
Drugs for Heart Failure
▶︎
AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎
Acute Kidney Injury (AKI) | Clinical Medicine
▶︎
Flying: Relaxing Sleep Music for Meditation, Stress Relief & Relaxation by Peder B. Helland
▶︎
Muscle Anatomy & Physiology- Dr. Jessica Guerrero
▶︎
Antihypertensive Drugs
▶︎
Asperger Syndrome: From Diagnosis to Independence - Social Development
▶︎
Sugar: THE BITTER TRUTH
▶︎
System Design Explained: APIs, Databases, Caching, CDNs, Load Balancing & Production Infra
▶︎
Mozart | Classical Music for Studying, Working & Brain Power
▶︎
LRR Microbiology for FMGE 2026 By Dr. Preeti Sharma
▶︎
Pediatric Pulmonary Hypertension: Where are we now? | Pediatric Grand Rounds with Ryan D Coleman, MD
▶︎
Mercodia Webinar: Glucagon Signaling in Obesity and Type 2 Diabetes
▶︎
Mercodia Webinar Novel Polypharmacological Treatment Options for Obesity and Diabetes
▶︎